DIVIS LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE1312.3012.55 (+0.97 %)
PREV CLOSE ( ) 1299.75
OPEN PRICE ( ) 1299.90
BID PRICE (QTY) 1311.75 (32)
OFFER PRICE (QTY) 1312.75 (61)
VOLUME 19134
TODAY'S LOW / HIGH ( )1294.20 1340.00
52 WK LOW / HIGH ( )851 1425.6
NSE1314.2013 (+1 %)
PREV CLOSE( ) 1301.20
OPEN PRICE ( ) 1310.00
BID PRICE (QTY) 1314.15 (14)
OFFER PRICE (QTY) 1314.20 (30)
VOLUME 602298
TODAY'S LOW / HIGH( ) 1293.55 1340.65
52 WK LOW / HIGH ( )850.25 1425
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Murali K Divi - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23(p)/divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300

Email mail@divislaboratories.com

Website www.divislaboratories.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
11Sep Disclosure of Voting results of AGM (
Divis Laboratories Ltd has informed BSE regarding the details of Voting..
10Sep Shareholder Meeting / Postal Ballot-O
Proceedings of 28th Annual General Meeting held on 10th September, 2018..
06Aug Notice Of 28Th Annual General Meeting
We enclose herewith Notice of the 28th Annual General Meeting of the Com..
30Jul Corporate Action- Fixes Book Closure
Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosur..
30Jul Annual General Meeting On September 1
We hereby inform you that 28th Annual General Meeting (AGM) of the membe..
Financials
Rs. in Millions
QTR Jun 18 ANNUAL 18
Net Profit2661.68695.8
Gross Profit 3584.1 12193.6
Operating Profit 4006.513631.1
Net Sales 9953.138372.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 5948.80 (0.56%)
M.Cap (Rs. in Cr)13700.46
Abbott India (BSE)
 7341.10 (0.36%)
M.Cap (Rs. in Cr)15599.33
Biocon (BSE)
 657.00 (3.25%)
M.Cap (Rs. in Cr)39429.00
Mercury Laboratories (BSE)
 419.90 (4.97%)
M.Cap (Rs. in Cr)50.39
Neuland Laboratories (BSE)
 585.00 (2.27%)
M.Cap (Rs. in Cr)750.55
Shareholding Pattern
PROMOTERS 52.02%
MUTUAL FUNDS/UTI 16.83%
NON-INSTITUTION 13.67%
FI/BANKS/INSURANCE 0.33%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.